Show
Sort by
-
- Journal Article
- A1
- open access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
-
- Miscellaneous
- open access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
-
- Journal Article
- A1
- open access
RNA viruses alter house dust mite physiology and allergen production with no detected consequences for allergenicity
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
- Journal Article
- A1
- open access
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent
-
- Journal Article
- A1
- open access
Granulocyte colony-stimulating factor : missing link for stratification of type 2-high and type 2-low chronic rhinosinusitis patients
-
- Journal Article
- A1
- open access
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
-
COVID‐19 vaccination with BNT162b2 and ChAdOx1 vaccines has the potential to induce nasal neutralizing antibodies
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial